Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?

Author:

Cadnapaphornchai Melissa A1,Ong Albert C M23ORCID

Affiliation:

1. Rocky Mountain Pediatric Kidney Center, Rocky Mountain Hospital for Children at Presbyterian St. Luke's Medical Center , Denver, CO , USA

2. Academic Nephrology Unit, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield , Sheffield , UK

3. Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK

Abstract

ABSTRACT ADPKD is the most common hereditary kidney disease and a major cause of kidney failure world-wide. Significant kidney enlargement occurs decades preceding loss of kidney function. However, the earliest clinical manifestations of disease have been less well characterized in young adults, a typically healthy population who do not often seek routine medical care. In this study, Martinez and colleagues report a high prevalence of hypertension among young adults (18–30 years) enrolled in the Spanish ADPKD registry REPQRAD. Their findings confirm previous studies in children and young adults with ADPKD and make a strong case for earlier screening and intervention within this age group.

Funder

Medical Research Council

Kidney Research UK

National Institutes of Health

PKD Charity

PKD Foundation

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference35 articles.

1. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease;Cadnapaphornchai;Clin J Am Soc Nephrol,2014

2. Prospective change in renal volume and function in children with ADPKD;Cadnapaphornchai;Clin J Am Soc Nephrol,2009

3. Randomized, placebo-controlled, phase 3B trial of tolvaptan in the treatment of children and adolescents with autosomal dominant polycystic kidney disease (ADPKD): 1-year data;Mekahli DG-W;Nephrol Dial Transplant,2021

4. Predictors of autosomal dominant polycystic kidney disease progression;Schrier;J Am Soc Nephrol,2014

5. The PROPKD Score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease;Cornec-Le Gall;J Am Soc Nephrol,2016

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3